Company: ATRA
Filing Date: 2025-03-07
Form Type: 10-K
Source: 0000950170-25-035507
Chunk: 244

Company: Atara Biotherapeutics, Inc.
Filing Date: 2025-03-07
Form: 10-K
Item: Item 1B
Chunk 244
---
 Applicable.

132

PART III

Certain information required by Part III is omitted from this Annual Report on Form 10-K since we intend to file our definitive proxy statement for our 2025 annual meeting of stockholders (the Definitive Proxy Statement), pursuant to Regulation 14A of the Securities Exchange Act of 1934, as amended, not later than 120 days after December 31, 2024, and certain information to be included in the Definitive Proxy Statement is incorporated herein by reference.

Item 10. Directors, Executive Officers and Corporate Governance

Information required by this Item is hereby incorporated by reference to our Definitive Proxy Statement.

We adopted an Insider Trading and Window Period Policy that governs the purchase, sale and other dispositions of its securities by our directors, officers and employees. We believe the Insider Trading and Window Period Policy is reasonably designed to promote compliance with insider trading laws, rules, and regulations, and any listing standards applicable to us.  A copy of our Insider Trading and Window Period Policy is filed as Exhibit 19.1 to this Annual Report.

Item 11. Executive Compensation

Information required by this Item is hereby incorporated by reference to our Definitive Proxy Statement.

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Information required by this Item is hereby incorporated by reference to our Definitive Proxy Statement.

Item 13. Certain Relationships and Related Transactions, and Director Independence

Information required by this Item is hereby incorporated by reference to our Definitive Proxy Statement.

Item 14. Principal Accountant Fees and Services

Information required by this Item is hereby incorporated by reference to our Definitive Proxy Statement.

133

PART IV

Item 15. Exhibits and Financial Statement Schedules

(a)(1)	Financial Statements.

The response to this portion of Item 15 is set forth under Item 8 above.

(a)(2)	Financial Statement Schedules.

All schedules have been omitted because they are not required or because the required information is given in the financial statements or notes thereto set forth under Item 8 above.

(a)(3)	Exhibits.

134

EXHIBIT INDEX

    Exhibit

    Incorporated by Reference
     
    Filed

    Number
     
    Exhibit Description
     
    Form

    Exhibit
     
    Filing Date
     
    Herewith

      3.1
     
    Amended and Restated Certificate of Incorporation of Atara